TABLE 1.

In vitro antiborrelial activity of vaccine recipient sera

SubjectAntiborrelial score/ELISA titer at:
30 days after dose 26 mo after dose 230 days after dose 3
12/3201/<803/5,120
23/2,5602/1603/10,240
33/1,2802/1604/10,240
4a3/<800/<801/<80
53/6400/804/10,240
60/3200/<803/5,120
72/3201/804/1,280
82/3201/<803/1,280
91/3202/803/2,560
103/3200/<803/2,560
113/3200/<803/5,120
121/1602/<803/5,120
133/3202/<803/2,560
143/1601/<803/1,280
152/800/<802/640
162/1600/803/1,280
172/1601/<803/1,280
182/1601/<803/2,560
192/1602/802/1,280
203/1602/<803/2,560
  • a All samples from this subject tested negative for antibodies to B. burgdorferi. The antiborrelial score at time zero (baseline) was 0.